Cancer researchers identify potential new class of drugs to treat blood and bone marrow cancers

(Cleveland Clinic) CLEVELAND - A new study by researchers in Cleveland Clinic's Taussig Cancer Institute and Lerner Research Institute describes a novel class of targeted cancer drugs that may prove effective in treating certain common types of leukemia. The results first appeared online in Blood Cancer Discovery.